Survey among retina specialists in Brazil about inflammatory reactions after intravitreal antiangiogenic therapy.
Gustavo Barreto MeloMagno FerreiraMaurício MaiaPublished in: Arquivos brasileiros de oftalmologia (2020)
Most specialists reported cases of early-onset inflammation after intravitreal injection of antiangiogenic agents. The incidence of irreversible complications was low. Aflibercept was the most common agent used. The causes of inflammation remain unknown, but we formulated some relevant hypotheses.